Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructurePierfrancesco Visaggi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
10.1111/apt.71001
10.1111/apt.71001
10.1136/gutjnl‐2023‐329873
10.1136/gutjnl‐2023‐329873
10.1053/j.gastro.2025.09.030
10.1053/j.gastro.2025.09.030
10.1016/j.cgh.2026.04.004
10.1016/j.cgh.2026.04.004
Dupilumab in Adults and Adolescents With Eosinophilic Esophagitis
10.1056/nejmoa2205982 · 2022
Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response
10.14309/ctg.0000000000000793 · 2025
10.1016/j.cgh.2026.03.025
10.1016/j.cgh.2026.03.025
Step‐Down Dupilumab Dosing Regimen in Patients With Eosinophilic Esophagitis: A Real‐World, Retrospective Study
10.1111/cea.70113 · 2025
10.14309/ajg.0000000000004088
10.14309/ajg.0000000000004088
No additional external references are available.